In vitro activity of flomoxef, fosfomycin, and amikacin versus a global panel of third-generation cephalosporin-resistant Enterobacterales and prediction of their ability in pairwise combinations to work as carbapenem-sparing regimens.
- DOI
- 10.1016/j.jgar.2026.08.032
- Published
- 2026 Sep 7
- Container
- Journal of global antimicrobial resistance
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jgar.2026.08.032,
title = {In vitro activity of flomoxef, fosfomycin, and amikacin versus a global panel of third-generation cephalosporin-resistant Enterobacterales and prediction of their ability in pairwise combinations to work as carbapenem-sparing regimens.},
author = {Brennan-Krohn T and Duffey M and Hawser S and Kothari N and Franceschi F and da Costa RMA},
year = {2026},
journal = {Journal of global antimicrobial resistance},
doi = {10.1016/j.jgar.2026.08.032},
url = {https://doi.org/10.1016/j.jgar.2026.08.032}
}RIS
TY - JOUR TI - In vitro activity of flomoxef, fosfomycin, and amikacin versus a global panel of third-generation cephalosporin-resistant Enterobacterales and prediction of their ability in pairwise combinations to work as carbapenem-sparing regimens. AU - Brennan-Krohn T AU - Duffey M AU - Hawser S AU - Kothari N AU - Franceschi F AU - da Costa RMA PY - 2026 JO - Journal of global antimicrobial resistance DO - 10.1016/j.jgar.2026.08.032 UR - https://doi.org/10.1016/j.jgar.2026.08.032 ER -
APA
T, B., M, D., S, H., N, K., F, F., & RMA, D. C. (2026). In vitro activity of flomoxef, fosfomycin, and amikacin versus a global panel of third-generation cephalosporin-resistant Enterobacterales and prediction of their ability in pairwise combinations to work as carbapenem-sparing regimens.. Journal of global antimicrobial resistance. https://doi.org/10.1016/j.jgar.2026.08.032
Source records
- pubmed · retrieved 2026-09-25T14:58:36.139Z